ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.150,71
-0,10%
S&P 500
5.303,27
0,12%
US Dollar vs BRL
5,1047
0,00%
Bitcoin
66.863,58
-0,32%
Brent Oil
83,76
0,00%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. IRIDEX Corporation (IRIX)

  7. IRIDEX Corporation (IRIX) Notícias

IRIX

IRIDEX (IRIX)

IRIDEX Corporation
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:IRIX
DataHoraFonteTítuloCódigoCompanhia
14/05/202418:07Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IRIXIRIDEX Corporation
14/05/202417:28Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRIXIRIDEX Corporation
14/05/202417:05GlobeNewswire Inc.Iridex Reports First Quarter 2024 Financial ResultsNASDAQ:IRIXIRIDEX Corporation
08/05/202417:05GlobeNewswire Inc.Iridex to Report First Quarter 2024 Financial Results on May 14, 2024NASDAQ:IRIXIRIDEX Corporation
26/03/202417:05GlobeNewswire Inc.Iridex Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:IRIXIRIDEX Corporation
20/03/202417:05GlobeNewswire Inc.Iridex Schedules Fourth Quarter and Full Year 2023 Financial Results and Update on Strategic Review Process for March 26, 2024NASDAQ:IRIXIRIDEX Corporation
06/02/202410:00GlobeNewswire Inc.Iridex Corporation Receives European Patent on MicroPulse TechnologyNASDAQ:IRIXIRIDEX Corporation
24/01/202410:00GlobeNewswire Inc.Iridex Announces First Patient Enrollment in MicroPulse® TLT Clinical Study Conducted in Collaboration with Imperial College Healthcare NHS TrustNASDAQ:IRIXIRIDEX Corporation
11/01/202420:45GlobeNewswire Inc.Iridex Launches New Iridex 532® and Iridex 577® Lasers in US Market Marking 35 Years of Laser Innovation in Treating Retina Disorders & GlaucomaNASDAQ:IRIXIRIDEX Corporation
28/12/202320:00GlobeNewswire Inc.Iridex Confirms Medicare Administrative Contractors Retired Local Coverage Determinations that Restricted CyclophotocoagulationNASDAQ:IRIXIRIDEX Corporation
27/11/202311:00GlobeNewswire Inc.Iridex Corporation Announces Successful Appeal for Revision of Recent Medicare LCDs to Provide Broader Coverage of CyclophotocoagulationNASDAQ:IRIXIRIDEX Corporation
14/11/202318:21GlobeNewswire Inc.Iridex Reports Third Quarter 2023 Financial Results and Business UpdateNASDAQ:IRIXIRIDEX Corporation
13/11/202311:00GlobeNewswire Inc.Iridex to Host Third Quarter Financial Results Conference Call on November 14, 2023NASDAQ:IRIXIRIDEX Corporation
26/10/202317:22GlobeNewswire Inc.Iridex to Report Third Quarter Financial Results on November 14, 2023NASDAQ:IRIXIRIDEX Corporation
21/09/202318:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRIXIRIDEX Corporation
29/08/202317:05GlobeNewswire Inc.Iridex Announces Strategic Review to Unlock Shareholder ValueNASDAQ:IRIXIRIDEX Corporation
10/08/202317:05GlobeNewswire Inc.Iridex Reports Second Quarter 2023 Financial ResultsNASDAQ:IRIXIRIDEX Corporation
27/07/202317:05GlobeNewswire Inc.Iridex to Report Second Quarter Financial Results on August 10, 2023NASDAQ:IRIXIRIDEX Corporation
28/06/202317:09Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:IRIXIRIDEX Corporation
15/06/202319:58Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IRIXIRIDEX Corporation
15/06/202317:08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IRIXIRIDEX Corporation
30/05/202317:10Edgar (US Regulatory)Specialized Disclosure Report (sd)NASDAQ:IRIXIRIDEX Corporation
24/05/202317:22Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:IRIXIRIDEX Corporation
11/05/202317:23Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:IRIXIRIDEX Corporation
11/05/202317:05GlobeNewswire Inc.Iridex Reports First Quarter 2023 Financial ResultsNASDAQ:IRIXIRIDEX Corporation
28/04/202317:28Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:IRIXIRIDEX Corporation
28/04/202317:22Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:IRIXIRIDEX Corporation
27/04/202317:05GlobeNewswire Inc.Iridex to Report First Quarter Financial Results on May 11, 2023NASDAQ:IRIXIRIDEX Corporation
07/04/202317:03Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:IRIXIRIDEX Corporation
09/03/202318:31Edgar (US Regulatory)Annual Report (10-k)NASDAQ:IRIXIRIDEX Corporation
 Apresentando as notícias mais relevantes sobre:NASDAQ:IRIX

Seu Histórico Recente

ASX
AEKN
LSE
HANA
Hansa Investment
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados